loadpatents
name:-0.022976875305176
name:-0.010612010955811
name:-0.00044798851013184
STREICHER; Ruediger Patent Filings

STREICHER; Ruediger

Patent Applications and Registrations

Patent applications and USPTO patent grants for STREICHER; Ruediger.The latest application filed is for "alkoxy pyrazoles as soluble guanylate cyclase activators".

Company Profile
0.13.21
  • STREICHER; Ruediger - Biberach an der Riss DE
  • Streicher; Ruediger - Biberach N/A DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Alkoxy Pyrazoles as Soluble Guanylate Cyclase Activators
App 20210121473 - ERTLE; Judith ;   et al.
2021-04-29
Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
Grant 9,029,544 - Wagner , et al. May 12, 2
2015-05-12
Specific Pde4b-inhibitors For The Treatment Of Diabetes Mellitus
App 20140228286 - Luippold; Gerd ;   et al.
2014-08-14
Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
Grant 8,703,793 - Wagner , et al. April 22, 2
2014-04-22
Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
App 20130053404 - Wagner; Holger ;   et al.
2013-02-28
Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
Grant 8,357,689 - Wagner , et al. January 22, 2
2013-01-22
Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
Grant 8,232,312 - Wagner , et al. July 31, 2
2012-07-31
Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
Grant 8,211,923 - Wagner , et al. July 3, 2
2012-07-03
Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
Grant 8,163,911 - Langkopf , et al. April 24, 2
2012-04-24
Tricyclic Pyridine Derivatives, Medicaments Containing Such Compounds, Their Use And Process For Their Preparation
App 20120053197 - WAGNER; Holger ;   et al.
2012-03-01
Tricyclic Pyridine Derivatives, Medicaments Containing Such Compounds, Their Use And Process For Their Preparation
App 20120046304 - WAGNER; Holger ;   et al.
2012-02-23
Arylsulphonylglycine Derivatives, The Preparation Thereof And Their Use As Medicaments
App 20110269761 - Langkopf; Elke ;   et al.
2011-11-03
Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
App 20110021550 - Wagner; Holger ;   et al.
2011-01-27
Pharmaceutical Composition Comprising A Pyrazole-o-glucoside Derivative
App 20100317575 - Pinnetti; Sabine ;   et al.
2010-12-16
Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyr- azol-3'-O-.beta.-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
Grant 7,838,500 - Kraemer , et al. November 23, 2
2010-11-23
Arylsulfonylaminomethylphosphonic Acid Derivatives, The Preparation Thereof And The Use Thereof As Pharmaceutical Compositions
App 20100261677 - Langkopf; Elke ;   et al.
2010-10-14
Substituted Arylsulfonylaminomethylphosphonic Acid Derivatives, Their Preparation And Their Use In The Treatment Of Type I And Ii Diabetes Mellitus
App 20100210594 - Wagner; Holger ;   et al.
2010-08-19
Substituted Arylsulfonylaminomethylphosphonic Acid Derivatives, Their Preparation And Their Use In The Treatment Of Type I And Ii Diabetes Mellitus
App 20100210595 - Wagner; Holger ;   et al.
2010-08-19
Substituted Arylsulphonylglycines, The Preparation Thereof And The Use Thereof As Pharmaceutical Compositions
App 20100130557 - Wagner; Holger ;   et al.
2010-05-27
Substituted Arylsulphonylglycines, The Preparation Thereof And The Use Thereof As Pharmaceutical Compositions
App 20100093703 - Wagner; Holger ;   et al.
2010-04-15
Crystalline Form Of 1' -(1-methylethyl)-4' -[(2-fluoro-4-methoxyphenyl)methyl]-5' -methyl-1h-pyrazol-3' -o-beta-d-glucopyranoside, A Method For Its Preparation And The Use Thereof For Preparing Medicaments
App 20090181905 - KRAEMER; Gerd ;   et al.
2009-07-16
Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyr- azol-3'-O-.beta.-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
Grant 7,524,822 - Kraemer , et al. April 28, 2
2009-04-28
Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyr- azol-3'-O-beta-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
App 20070244176 - Kraemer; Gerd ;   et al.
2007-10-18
Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives
App 20070072813 - Himmelsbach; Frank ;   et al.
2007-03-29
Use of substituted 2-phenylbenzimidazoles as medicaments
Grant 7,151,114 - Streicher , et al. December 19, 2
2006-12-19
Bicyclic oligopeptides
Grant 7,101,848 - Potterat , et al. September 5, 2
2006-09-05
Cyanothiophenes, their preparation and their use in pharmaceutical compositions
App 20060094764 - Anderskewitz; Ralf ;   et al.
2006-05-04
Use of substituted 2 phenylbenzimidazoles as medicaments
App 20050014810 - Streicher, Ruediger ;   et al.
2005-01-20
Bicyclic oligopeptides
App 20040072736 - Potterat, Olivier ;   et al.
2004-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed